NHP NHP

Q: What is the current share price of NHP?

As of 2026-08-05 17:25 PDT, NHP trades at $16.03 on NASDAQ/NYSE. Its 52-week range is $11.94 to $16.15.

Q: What is the market capitalisation of NHP?

NHP has a market capitalisation of $455.68M on NASDAQ/NYSE.

Q: What is the P/E ratio of NHP?

NHP trades at a trailing price-to-earnings (P/E) ratio of -6.39. Its price-to-book (P/B) ratio is 0.76.

Q: What is the return on equity (ROE) of NHP?

NHP has a return on equity (ROE) of -9.60%. Its return on capital employed (ROCE) is 1.85%.

Q: Is NHP a good stock to buy?

This page provides a data-driven analysis of NHP, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Company Profile ↓

$16.03

+34.23% 1Y

Mkt Cap$455.68M

P/E-6.39

P/B0.76

52W High$16.15

52W Low$11.94

Book Value$21.11

EPS (TTM)$-2.51

Company Overview

NHP (NHP) is a publicly traded company listed on with a market capitalization of $455.68M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 61.0% CAGR over the past five years.

Recent Developments

Dec 2025 Revenue of $342.28M (-3.3% YoY); net profit $-57.62M.
Trailing 12 Months Year-on-year growth — revenue -3.2%.
5-Year Trend Long-term compounding — revenue CAGR 61.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	61.00%
1 Year:	-3.25%

Stock Price Performance

1 Year:	+34.23%
6 Months:	-
3 Months:	+23.24%
1 Month:	+3.92%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot

52-Week Range 97% of range

$11.94 $16.15

Trend Signals

Price vs 50-DMAAbove
RSI (14)60.39 · Neutral

Price Performance

1M+3.92%

3M+23.24%

1Y+34.23%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Compounding revenue at 61.0% over 5 years.

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

-6.39

Industry PE

Forward P/E

PEG Ratio

Book Value

$21.11

Price to Book

0.76

P/S

EV/EBITDA

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

61.00%

Profit 5Y

Revenue (YoY)

-3.25%

Earnings (YoY)

Profitability & Returns

ROCE

1.85%

ROE

-9.60%

ROA

-3.37%

Profit Margin

-16.83%

Op Margin

6.11%

Gross Margin

36.05%

EPS (Latest Qtr)

$-0.27

EPS (TTM)

$-2.51

Balance Sheet & Liquidity

Debt/Equity

1.74

Quick Ratio

Current Ratio

0.24

Debt

$1.05B

Total Assets

$1.70B

Current Assets

$137.55M

Working Capital

$-438.52M

Ownership

Promoter Holding

0.00%

Chg in Prom Hold

0.00%

FII / Inst Holding

48.22%

Chg in FII Hold

0.00%

Financial Snapshot

Enterprise Value

Total Revenue (TTM)

$342.28M

EBITDA

$82.02M

Free Cash Flow

$-21.77M

Operating Cash Flow

$6.95M

Shares Outstanding

28.43M

Gross Margin

36.05%

Payout Ratio

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	64.03M	66.37M	75.51M	75.86M	75.52M	75.68M	74.61M	75.77M	79.07M	81.72M	89.44M	90.96M	90.19M	91.82M	88.72M	96.29M	95.44M	94.47M	100.23M	94.66M	95.83M	90.88M	83.44M	81.16M	82.01M	83.65M	83.83M	83.46M	87.36M	86.10M	85.69M	88.30M	88.82M	88.94M	-	86.44M	85.33M	86.03M	84.48M	86.28M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	57.86M	53.85M	53.84M	53.02M	52.92M
Gross Profit	30.49M	-	36.71M	34.94M	31.56M	-	32.00M	31.41M	30.63M	-	36.33M	37.20M	30.89M	-	35.92M	37.48M	34.78M	-	38.51M	34.88M	34.16M	-	34.08M	29.60M	30.79M	30.56M	31.23M	32.26M	33.47M	32.53M	31.36M	33.15M	33.81M	32.53M	-	28.59M	31.48M	32.18M	31.46M	33.37M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28.60M	23.95M	23.70M	26.54M	23.20M
Operating Income	-13.71M	-	2.92M	844.00K	-4.90M	-	-817.00K	1.27M	-16.33M	-	5.28M	5.84M	-17.63M	-	9.23M	6.99M	-16.09M	-	-10.52M	-9.94M	3.61M	-	862.00K	-2.12M	-28.61M	-12.60M	-5.94M	-8.35M	1.94M	813.00K	-912.00K	-1.12M	-100.44M	-20.93M	-	-15.00K	7.54M	8.48M	4.92M	10.16M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	36.73M	13.54M	20.62M	11.14M	28.20M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14.54M	15.84M	15.06M	15.86M	14.67M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.52M	-20.83M	-12.47M	-22.70M	-4.20M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6.00K	0	66.00K	101.00K	77.00K
Net Income	-16.11M	-6.99M	-1.55M	-3.00M	-8.66M	-7.66M	-6.14M	-4.72M	-24.14M	-7.56M	-5.99M	-6.95M	-29.61M	-10.24M	-5.11M	-6.05M	-28.79M	-48.13M	-24.74M	-22.81M	-10.50M	-20.73M	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.57M	-20.80M	-12.55M	-22.70M	-4.31M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.23	-0.11	-	-0.12	-0.15	-0.40	-0.25	-0.19	-0.21	-0.15	-0.18	-0.69	-0.67	-4.24	-1.56	-	-0.18	-0.85	-0.56	-0.92	-0.27

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	1.82M	58.44M	247.49M	302.57M	311.17M	362.41M	374.91M	381.61M	-	335.85M	345.93M	353.79M	342.28M
Cost of Revenue	-	-	-	-	-	-	-	-	-	213.44M	217.79M	221.45M	218.90M
Gross Profit	1.70M	31.72M	121.92M	130.49M	124.90M	141.41M	140.73M	138.06M	-	122.40M	128.13M	132.34M	123.38M
Operating Expenses	-	-	-	-	-	-	-	-	-	124.70M	127.33M	125.71M	102.45M
Operating Income	-216.00K	-34.33M	-35.61M	-3.31M	-12.22M	-3.18M	-31.79M	-19.87M	-	-2.30M	805.00K	6.63M	20.93M
EBITDA	-	-	-	-	-	-	-	-	-	54.38M	76.87M	-36.49M	82.02M
Interest Expense	-	-	-	-	-	-	-	-	-	51.74M	66.08M	69.45M	61.28M
Pretax Income	-	-	-	-	-	-	-	-	-	-79.42M	-72.08M	-190.00M	-57.52M
Tax Provision	-	-	-	-	-	-	-	-	-	201.00K	303.00K	262.00K	161.00K
Net Income	-221.00K	-37.68M	-41.74M	-20.87M	-42.55M	-52.76M	-88.09M	-78.78M	-	-79.49M	-72.30M	-189.70M	-57.62M
Diluted EPS	-	-	-	-	-	-	-0.88	-0.74	-	-3.30	-3.04	-7.19	-2.51

Balance Sheet (Annual)

Figures in USD.

Metric	Oct 2012	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	810.00K	160.21M	1.86B	2.27B	2.19B	2.37B	2.38B	2.33B	2.29B	-	2.18B	2.15B	1.95B	1.71B
Current Assets	-	-	-	-	-	-	-	-	-	-	-	101.81M	117.64M	102.79M	139.19M
Cash & Equivalents	0	3.00K	111.83M	182.62M	24.47M	29.23M	94.18M	77.26M	95.69M	72.36M	-	53.65M	46.41M	21.65M	57.62M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	25.28M	26.32M	28.69M	30.74M
Total Liabilities	-	625.00K	2.06M	125.53M	668.02M	689.38M	1.02B	1.14B	1.22B	1.33B	-	1.18B	1.24B	1.26B	1.11B
Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	584.97M	419.38M	462.50M	577.71M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	578.70M	809.00M	779.16M	516.03M
Total Debt	-	-	-	-	-	-	-	-	-	-	-	1.12B	1.18B	1.15B	1.05B
Total Equity	0	185.00K	158.15M	1.72B	1.59B	1.50B	1.35B	1.23B	1.10B	956.99M	-	992.64M	894.15M	684.56M	600.06M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	105.08M	111.55M	28.30M	28.43M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-764.00K	-6.46M	68.68M	78.72M	63.97M	54.15M	47.40M	41.81M	-	28.30M	21.62M	-79.85M	6.95M
Investing Cash Flow	-46.48M	-1.53B	-556.83M	-19.09M	-194.41M	-115.06M	-46.25M	-82.49M	-	-41.78M	-62.82M	63.97M	69.81M
Financing Cash Flow	159.08M	1.61B	332.88M	-55.57M	199.84M	49.68M	19.09M	19.43M	-	4.64M	55.97M	-1.35M	-42.40M
Capital Expenditure	-0	-807.00K	-6.88M	-7.48M	-8.28M	-12.91M	-16.72M	-	-	-27.99M	-22.40M	-21.91M	-28.73M
Free Cash Flow	-764.00K	-7.27M	61.80M	71.25M	55.69M	41.24M	30.68M	-	-	302.00K	-773.00K	-101.75M	-21.77M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-8.84M	14.78M	-17.22M	34.36M
Share Buybacks	0	541.00K	10.41M	12.18M	33.60M	14.20M	21.11M	10.54M	0	0	-	-	-
Dividends Paid	1.30M	35.16M	66.21M	75.43M	76.72M	55.33M	51.43M	-	-	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	93.3%	54.3%	49.3%	43.1%	40.1%	39.0%	37.5%	36.2%	-	36.4%	37.0%	37.4%	36.0%
Operating Margin %	-11.9%	-58.7%	-14.4%	-1.1%	-3.9%	-0.9%	-8.5%	-5.2%	-	-0.7%	0.2%	1.9%	6.1%
Net Margin %	-12.2%	-64.5%	-16.9%	-6.9%	-13.7%	-14.6%	-23.5%	-20.6%	-	-23.7%	-20.9%	-53.6%	-16.8%
ROE %	-0.1%	-2.2%	-2.6%	-1.4%	-3.2%	-4.3%	-8.0%	-8.2%	-	-8.0%	-8.1%	-27.7%	-9.6%
ROCE %	-	-	-	-	-	-	-	-	-	-0.1%	0.0%	0.4%	1.8%

Shareholding Pattern

Insiders

0.00%

Institutions

48.22%

Public Float

48.22%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NHP

Google News Wed, 05 Aug 2026

National Healthcare Properties Announces Redemption of All Outstanding Preferred Stock - GlobeNewswire

<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxNRHJzODUwM2JWeHEwMG90d2dNbU00WHNlY1RmamVfWldBcll4ZUN5aUhiTXJvMVhJTTNtR2tSQ0JPS085NFluWUUwMzU0dTlBemFmUUp4QTBRVmxMNVZsZm04WlU1V1o4RXB4aUJNa0dvNTE0aXF1TzM3V2UyWXZpWXJzN3lzWFd4MlNQa1…

Google News Wed, 05 Aug 2026

National Healthcare Properties reports Q2 net loss as SHOP NOI rises 20.1% - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNd3RPNWNtYnFmSWtuRDVxem1IOUI1T1NfWU8xeEFzWjk0eTFhYzJ5V1FsZV90TFNTOGR1cmVHMTFLWHpWZXNnWDZJdnl3VndrdkE0aUdvOVdEMXRQSlR4azlSckZLNEpZNjExX0lBOU5xaDZyazQtcXVNMXY5ZlpPRWlEd1NNT3kzQVNUVF…

Google News hu, 23 Apr 2026

symbol__ Stock Quote Price and Forecast - CNN

<a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTFBFNnZ1NW1xTm5md3ZmQU5QaTZONXE2LWRxTFZoa1ltZjRmRDNYTFVlbzVvSjFYU3pNMzFjUmRfWll5UTMzX1JtNG9nZV9pZ1k?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a>  <font…

Google News Sat, 01 Aug 2026

NHP Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE5XWmFFVy1mMm5zTS1fTnN4NGtaODVra0FGTFQ3TXF4YnR6bGxUeE5Kc2VldFJKblZ6djQ4MUVQV0lYaFhMaC1hS0JhUVFZS0o1NFFYdkNJMHZ2dkZ4MTEzeHRyaXh2VWMxdENET2dKbVQzQ2k1c09iMw?oc=5" target="_blank">NHP F…

Google News Wed, 05 Aug 2026

Top Medical Properties Trust (MPT) Competitors 2026 - MarketBeat

<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTFBnSjMzOThLOU9ydlhXcnMxeWptNlJPWFhJV25Jc0t4NU5Sb2ZwUEI3RTNvWElYNGZnNXdMeElCeklLeTY5djFZSjB0QWh4ZjE2UnFjSmVadWxvMThwWUR1cC1CbjN5cldJVkt4MTFlcFlzd1pvUmlzWXpGcDc?oc=5" target="_blank">…

Google News Wed, 17 Jun 2026

National Healthcare Properties board neutral on unsolicited ‘mini-tender’ offer from MacKenzie - McKnight's Senior Living

<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxNVklvVE5NLUJrbjU1ZmRQWnBtS3hBckRyUWRaRnl4TWtkVDJrZm9hNHUxdjFub3lPTDIycUNQejZSSUhhOWlfWHdmRjc3M29oVk0tSkdrdWpMZVFCQlQtVFBVQmJscTE5Qld2NmJNd3hxS2stWlMtRUR3bVZjTmI2TGtXQVZ2UmVGa1d4bF…

NHP — Frequently Asked Questions

What is the current share price of NHP?

As of 2026-08-05 17:25 PDT, NHP trades at $16.03 on NASDAQ/NYSE. Its 52-week range is $11.94 to $16.15.

What is the market capitalisation of NHP?

NHP has a market capitalisation of $455.68M on NASDAQ/NYSE.

What is the P/E ratio of NHP?

NHP trades at a trailing price-to-earnings (P/E) ratio of -6.39. Its price-to-book (P/B) ratio is 0.76.

What is the return on equity (ROE) of NHP?

NHP has a return on equity (ROE) of -9.60%. Its return on capital employed (ROCE) is 1.85%.

Is NHP a good stock to buy?

This page provides a data-driven analysis of NHP, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

NHP NHP

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Analyst View

Latest News

National Healthcare Properties Announces Redemption of All Outstanding Preferred Stock - GlobeNewswire

National Healthcare Properties reports Q2 net loss as SHOP NOI rises 20.1% - Quiver Quantitative

symbol__ Stock Quote Price and Forecast - CNN

NHP Forecast — Price Target — Prediction for 2027 - TradingView

Top Medical Properties Trust (MPT) Competitors 2026 - MarketBeat

National Healthcare Properties board neutral on unsolicited ‘mini-tender’ offer from MacKenzie - McKnight's Senior Living

NHP — Frequently Asked Questions

What is the current share price of NHP?

What is the market capitalisation of NHP?

What is the P/E ratio of NHP?

What is the return on equity (ROE) of NHP?

Is NHP a good stock to buy?

Explore More